Study: Deaths from most common lung cancer fall sharply as treatments advance
Incidence-based mortality for the most common U.S. lung cancer fell about 6% per year between 2013 and 2016 as treatment advances accelerated previous declines, according to a study reported this week in the New England Journal of Medicine.
“This analysis shows for the first time that nationwide mortality rates for the most common category of lung cancer, non-small cell lung cancer, are declining faster than its incidence, an advance that correlates with the U.S. Food and Drug Administration approval of several targeted therapies for this cancer in recent years,” said Douglas Lowy, M.D., National Cancer Institute deputy director and co-author of the study.
Related News Articles
Chairperson's File
We know that health equity matters. But what exactly does the term mean? AHA’s Institute for Diversity and Health Equity defines “health equity” as “The fair…
Headline
The AHA’s Hospital Community Collaborative has released "Healthier Together," a report about the program’s impact on community health throughout the country.…
Blog
The greatest success story of the 20th century is longevity. This is especially true in the United States, where average life expectancy at birth rose by more…
Headline
The Centers for Medicare & Medicaid Services July 10 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Chairperson's File
Hospitals and health systems have a long history of leading initiatives that improve individual and community health. By partnering with community-based…
Headline
The Department of Health and Human Services July 2 announced it will provide Medicaid and Children's Health Insurance Program coverage to incarcerated people…